anthrax toxin receptor 1 (ANTXR1)
Nov 09, 2018
Triple Negative Breast Cancer
What is Triple Negative Breast Cancer? Triple Negative Breast Cancer (TNBC) is defined as a heterogeneous breast cancer phenotype where the estrogen and progesterone receptor are negative, and there is a lack of overexpression of HER2, as assessed by immunohistochemistry (IHC), or the absence of its gene amplificati...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
